Nocardithiocin is a novel thiopeptide compound produced by the pathogenic Nocardia pseudobrasiliensis strain IFM 0757. It shows a strong activity against acid-fast bacilli such as the Mycobacterium and Gordonia species. Nocardithiocin was highly active against rifampicin-resistant as well as -sensitive Mycobacterium tuberculosis strains, and most of the resistant strains were inhibited at concentrations ranging from 0.025 to 1.56 μg ml 1. The structure of the thiopeptide antibiotic containing thiazole, natural and unnatural amino acids was elucidated by MS and NMR spectral analyses. © 2009 Japan Antibiotics Research Association. All rights reserved.
CITATION STYLE
Mukai, A., Fukai, T., Hoshino, Y., Yazawa, K., Harada, K. I., & Mikami, Y. (2009). Nocardithiocin, a novel thiopeptide antibiotic, produced by pathogenic Nocardia pseudobrasiliensis IFM 0757. Journal of Antibiotics, 62(11), 613–619. https://doi.org/10.1038/ja.2009.90
Mendeley helps you to discover research relevant for your work.